Skip to content
healthcare.dev

lamotrigine

NDC 62332-096, lamotrigine, tablet, for suspension, from Alembic Pharmaceuticals Inc..

Product NDC
62332-096
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201168
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-096 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE25 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
62332-096-306233200963030 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-30)
62332-096-3162332009631100 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-31)
62332-096-91623320096911000 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/05cba628-b12c-44d8-89a8-3522fe417cc1
  • NADAC price for package 62332009631

    GET /v1/drugs/nadac/62332009631

Use it

Look up 62332-096 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-096 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-096. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.